A real-world characterization of a population with eosinophilic esophagitis: looking for severity biomarkers

被引:0
|
作者
Caldeira, Leonor esteves [1 ]
Limao, Rita [1 ]
Bras, Rita [1 ]
Pedro, Elisa [1 ]
Costa, Celia [1 ,2 ]
机构
[1] Ctr Hosp Univ Lisboa Norte EPE, Hosp Santa Maria, Dept Immunoallergol, Lisbon, Portugal
[2] Univ Clin Immunoallergol, Med Fac Lisbon, Lisbon, Portugal
关键词
Atopy; eosinophilic esophagitis; food allergy; sensitization; severity biomarkers; HISTOLOGIC REMISSION; GUIDELINES; MANAGEMENT; DIAGNOSIS; EFFICACY; CHILDREN;
D O I
10.23822/EurAnnACI.1764-1489.292
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background. Eosinophilic esophagitis (EoE) is an immune-mediated chronic esophageal disease, with frequent association with atopy. A vali- dated non/minimally invasive biomarker of disease severity has not been identified. We aimed to determine if sensitization to airborne , food allergens correlates with disease severity , to evaluate the association between clinical and laboratory characteristics with the severity of EoE. Methods. Retrospective study of EoE patients observed in a differentiated center, 2009-2021. The association between patients' diagnosis age, disease duration before diagnosis, sensitization to airborne/food allergens, serum total IgE and peripheral blood eosinophil values and severe clinical disease (presence of symptoms with a significant impact on quality of life and/or >= 1 hospital admission due to EoE complications, namely severe dysphagia, food impaction or esophageal perforation) and histological severe disease (>= 55 eos/hpf and/or microabscesses in esophageal biopsies) was evaluated. Results. 92 patients were observed, 83% male, 87% atopic. There was a mean delay in diagnosis of 4 years (range 0-31). 84% had aeroallergen sensitization and 71% food sensitization. Food impaction and dysphagia were the most frequent symptoms, and severe clinical disease was observed in 55%. Histologically, 37% had severity criteria. Patients with severe clinical disease had a significantly longer mean disease duration before diagnosis than patients without severe clinical disease (79 vs 15 months; p = 0.021). Patients who described food impaction were significantly older at time of diagnosis than those who have never had impaction (18 vs 9 years; p < 0.001). There was no significant association (p < 0.05) between sensitization, serum total IgE and peripheral blood eosinophil values and clinical or histological severity. Conclusions. An older age at diagnosis and a longer disease duration before diagnosis appear to be useful for pre- dicting EoE clinical severity. Despite having been demonstrated a high prevalence of allergic disease, the presence of sensitization to airborne and/ or food allergens do not seem to be useful for predicting clinical or histo- logical severity.
引用
收藏
页码:252 / 262
页数:11
相关论文
共 50 条
  • [1] Real-World Effectiveness and Use of Dupilumab in Eosinophilic Esophagitis
    Russin, Michelle
    Chen, Joan W.
    Rubenstein, Joel H.
    Chang, Joy W.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S397 - S398
  • [2] Efficacy of Therapy for Eosinophilic Esophagitis in Real-World Practice
    Laserna-Mendieta, Emilio J.
    Casabona, Sergio
    Savarino, Edoardo
    Perello, Antonia
    Perez-Martinez, Isabel
    Guagnozzi, Danila
    Barrio, Jesus
    Guardiola, Antonio
    Asensio, Teresa
    de la Riva, Susana
    Ruiz-Ponce, Miriam
    Rodriguez-Oballe, Juan Armando
    Santander, Cecilio
    Arias, Angel
    Lucendo, Alfredo J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (13) : 2903 - +
  • [3] Real-World Effectiveness and Use of Dupilumab in Eosinophilic Esophagitis
    Russin, Michelle
    Chen, Joan
    Rubenstein, Joel H.
    Chang, Joy W.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2025, 120 (03): : 663 - 666
  • [4] REAL-WORLD TREATMENT PATTERNS AND PERSISTENCE IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
    Dellon, Evan S.
    Xia, Qian
    Qian, Ellen W.
    Kumari, Simran
    Tencer, Tom
    GASTROENTEROLOGY, 2022, 162 (07) : S529 - S529
  • [5] CHARACTERIZATION OF PATIENTS WITH EOSINOPHILIC ESOPHAGITIS MANAGED BY GASTROENTEROLOGISTS AND ALLERGISTS: REAL-WORLD CLINICAL PRACTICE EVIDENCE
    Xu, X.
    Kwiatek, J.
    Siddall, J.
    Genofre, E.
    Stirnadel-Farrant, H.
    Katial, R.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S78 - S78
  • [6] A Real-World Experience of Dupilumab in Saudi Adults With Eosinophilic Esophagitis: A Retrospective Study
    Alnajjar, Asma
    Najmi, Muath
    Alqaraawi, Abdullah
    Alsohaibani, Fahad
    Almuhaidb, Aymen
    Alfadda, Abdulrahman
    Ahmed, Mohamed
    Desai, Sameer
    Peedikayil, Musthafa
    Alajlan, Bader
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S399 - S400
  • [7] Real-world outcomes in patients with eosinophilic esophagitis taking budesonide orodispersible tablets
    Taylor, S.
    Lucas, S.
    Chauhan, A.
    Yu, C.
    Tan, K.
    Lewis, D.
    Garg, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 209 - 210
  • [8] Opportunities for Virtual Care in Eosinophilic Esophagitis: Real-World Dietary Therapy Practice
    Russin, Michelle
    Chang, Joy W.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S305 - S305
  • [9] REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AND ASSOCIATED COSTS IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
    Tencer, T.
    Xia, Q.
    Jobson, G.
    Qian, E.
    Dellon, E. S.
    VALUE IN HEALTH, 2022, 25 (07) : S432 - S432
  • [10] Real-World Challenges in Piloting a Digital Health Diet Education Intervention in Eosinophilic Esophagitis
    Russin, Michelle
    Lynett, Amanda
    Haller, Emily
    Rubenstein, Joel H.
    Wallner, Lauren P.
    Chang, Joy W.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S398 - S399